CTSS and gastric cancer: To develop a highly sensitive and specific NIRFI system for early gastric cancer screening, Ding and colleagues [62] validated the feasibility of NIRFI for gastric cancer screening using Cathepsin-activatable and matrix metalloproteinase (MMP)-activatable molecular probes in a mouse model.